Ledger.Open graph →
SEC Form D · filed November 27, 2013

IMPEL NEUROPHARMA INC

Offering
$3.8M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Brian D. Zelickson · Minneapolis, MNExec · DirectorRodney Ho · Seattle, WADirectorHGI Opportunity Select Fund V Managing Co., LLC · Norfolk, VAExec · DirectorJohn Corpus · Denver, COExec · DirectorDouglas J. Jacobson · Oklahoma City, OKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗